Journal
TOXINS
Volume 13, Issue 1, Pages -Publisher
MDPI
DOI: 10.3390/toxins13010042
Keywords
botulinum toxin; movement disorders; tremors; dystonia; tics; bruxism; restless legs syndrome; Parkinson’ s disease; myoclonus; dyskinesia
Categories
Ask authors/readers for more resources
BoNT has evolved into a therapeutic modality for a variety of neurological and non-neurological disorders since its initial approval in 1989. It has shown effectiveness in treating neurologic movement disorders and is being researched for potential central nervous system applications. BoNT is considered safe when administered by knowledgeable clinicians and has shown promise in recent innovative pilot studies.
Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a therapeutic modality for a variety of neurological and non-neurological disorders. With respect to neurologic movement disorders, BoNT has been reported to be effective for the treatment of dystonia, bruxism, tremors, tics, myoclonus, restless legs syndrome, tardive dyskinesia, and a variety of symptoms associated with Parkinson's disease. More recently, research with BoNT has expanded beyond its use as a powerful muscle relaxant and a peripherally active drug to its potential central nervous system applications in the treatment of neurodegenerative disorders. Although BoNT is the most potent biologic toxin, when it is administered by knowledgeable and experienced clinicians, it is one of the safest therapeutic agents in clinical use. The primary aim of this article is to provide an update on recent advances in BoNT research with a focus on novel applications in the treatment of movement disorders. This comprehensive review of the literature provides a critical review of evidence-based clinical trials and highlights recent innovative pilot studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available